Risk for retinal detachment not increased with fluoroquinolones

Cox, Amber; Shafer, Emily
December 2013
Infectious Disease News;Dec2013, Vol. 26 Issue 12, p12
The article reports that the risk for retinal detachment did not increase among people who use oral fluoroquinolone, according to a study by researchers from the Statens Serum Institut in Copenhagen, Denmark, as of December 2013.


Related Articles

  • News@JAMA.  // JAMA: Journal of the American Medical Association;5/9/2012, Vol. 307 Issue 18, p1903 

    The article discusses several reports which were published in the daily news site of the periodical, including one on the American Society of Clinical Oncology's list of unproven tests or treatments for cancer, one on the retinal detachment risk associated with fluoroquinolone use, and on the...

  • Incidence Rates of Retinal Detachment in 2 Cohorts of Patients Treated With Oral Fluoroquinolones or Amoxicillin. Farioli, Andrea; Kriebel, David // Clinical Infectious Diseases;May2014, Vol. 58 Issue 10, p1489 

    A letter to the editor is presented in response to the article "Association between recent use of fluoroquinolones and rhegmatogenous retinal detachment" by S.C. Kuo and colleagues in the previous issue.

  • Flouroquinolones and Retinal Detachment.  // Nutrition Health Review: The Consumer's Medical Journal;2011, Issue 107, p15 

    The article focuses on a population based study which reveals risk of retinal detachment in patients using oral flouro-quinolone antibiotics.

  • Exposure to Oral Fluoroquinolones and the Risk of Retinal Detachment: Retrospective Analyses of Two Large Healthcare Databases. Fife, Daniel; Zhu, Vivienne; Voss, Erica; Levy-Clarke, Grace; Ryan, Patrick // Drug Safety;Mar2014, Vol. 37 Issue 3, p171 

    Background: A recent Canadian case-control study reported a 4.5-fold increased risk of retinal detachment (RD) during oral fluoroquinolone use. Of the fluoroquinolone-exposed cases, 83 % were exposed to ciprofloxacin. We sought to replicate this finding, and assess whether it applied to all...

  • Oral antibiotic use may be linked to elevated risk of retinal detachment.  // Ocular Surgery News;9/25/2012, Vol. 30 Issue 18, Special section p8 

    The article discusses the results of study, tackled by David Maberley during the 2012 American Society of Retina Specialists Meeting held in Las Vegas, Nevada, which examined the correlation between the use of oral fluoroquinolones and the risk of retinal detachment.

  • Oral fluoroquinolone use may increase risk of retinal detachment. Hasson, Matt // Ocular Surgery News;11/10/2012, Vol. 30 Issue 21, p55 

    The article discusses a case control study determining the association of oral fluoroquinolone with an increase risk of retinal detachment and tendon rupture. The findings revealed that although fluoroquinolone are among most commonly prescribed drugs in the U. S., patients using this drug...

  • Association Between Recent Use of Fluoroquinolones and Rhegmatogenous Retinal Detachment: A Population-Based Cohort Study. Kuo, Shu-Chen; Chen, Yung-Tai; Lee, Yi-Tzu; Fan, Nai-Wen; Chen, Shih-Jen; Li, Szu-Yuan; Liu, Chia-Jen; Chen, Te-Li; Chen, Tzeng-Ji; Fung, Chang-Phone // Clinical Infectious Diseases;Jan2014, Vol. 58 Issue 2, p197 

    An association between use of oral fluoroquinolones and retinal detachment has been described but remains controversial. The current study found that recent use of an oral fluoroquinolone is significantly associated with rhegmatogenous retinal detachment. Hazard ratios differ for specific...

  • Macular hole surgery is high risk. Kuznar, Wayne // Ophthalmology Times;2/13/95, Vol. 20 Issue 7, p16 

    Reports that vitrectomy for macular hole carries the risk of significant posterior segment complications like retinal detachment and retinal break. Incidence of posterior segment complications after vitreous surgery for macular hole in the United States; Anatomic closure of eyes; Disturbance in...

  • Bevacizumab.  // Reactions Weekly;9/8/2012, Issue 1418, p14 

    The article describes the case of a retrospective study identified four men, aged 24-29 years, who experienced rhegmatogenous retinal detachment after receiving bevacizumab for Eales disease.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics